Clinical Imaging
Volume 34, Issue 2 , Pages 109-112 , March 2010

Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET

  • Chun Y. Lin

      Affiliations

    • Department of Nuclear Medicine, Show Chwan Memorial Hospital, Changhua
    • ,
  • Hueisch J. Ding

      Affiliations

    • Department of Medical Imaging and Radiological Services, I-Shou University, Kaohsiung
    • ,
  • Tsann Lin

      Affiliations

    • Department of Community Medicine and Health Examination Center, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Cheng C. Lin

      Affiliations

    • Department of Community Medicine and Health Examination Center, China Medical University Hospital, Taichung, Taiwan
    • Corresponding Author InformationCorresponding authors. Department of Nuclear Medicine and PET Center, and Department of Community Medicine and Health Examination Center, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan. Tel.: +886 4 22052121x7412; fax: +886 4 22336174.
    • ,
  • Tsung H. Kuo

      Affiliations

    • Department of Pulmonology, Show Chwan Memorial Hospital, Changhua
    • ,
  • Chia H. Kao

      Affiliations

    • Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
    • Corresponding Author InformationCorresponding authors. Department of Nuclear Medicine and PET Center, and Department of Community Medicine and Health Examination Center, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan. Tel.: +886 4 22052121x7412; fax: +886 4 22336174.

Received 10 March 2009 ,Accepted 1 May 2009.

References 

  1. Răileanu I, Rusu V, Stefănescu C, Cinotti L, Hountis D. 18F FDG PET—applications in oncology. Rev Med Chir Soc Med Nat Iasi. 2002;106(1):14–23
  2. Son HB, Han CJ, Kim BI, Kim J, Jeong SH, Kim YC, et al. Evaluation of various hepatic lesions with positron emission tomography. Taehan Kan Hakhoe Chi. 2002;8(4):472–480
  3. Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26(8):671–687
  4. Cook GJ. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging. 2007;51(3):235–243
  5. Truong MT, Pan T, Erasmus JJ. Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging. 2006;21(2):lll–22
  6. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med. 2004;34(2):122–133
  7. Kato T, Tsukamoto E, Suginami Y, Mabuchi M, Yoshinaga K, Takano A, et al. Visualization of normal organs in whole-body FDG-PET imaging. Kaku Igaku. 1999;36(9):971–977
  8. Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol. 2008;97(8):649–652
  9. Heusner TA, Freudenberg LS, Kuehl H, Hauth EA, Veit-Haibach P, Forsting M, et al. Whole-body PET/CT-mammography for staging breast cancer: initial results. Br J Radiol. 2008;81(969):743–748
  10. Bouchelouche K, Oehr P. Recent developments in urologic oncology: positron emission tomography molecular imaging. Curr Opin Oncol. 2008;20(3):321–326
  11. Roarke MC, Nguyen BD, Pockaj BA. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT. Clin Nucl Med. 2008;33(8):562–564
  12. Mahmood S, Martinez de Llano SR. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Clin Nucl Med. 2008;33(7):510–512
  13. Acar C, Akkas BE, Sen I, Sozen S, Kitapci MT. False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int. 2008;80(4):444–447
  14. Dong MJ, Lin XT, Zhao J, Guan YH, Zuo CT, Chen X, et al. Malignant tumor with false negative 18F-FDG PET image. Zhonghua Zhong Liu Za Zhi. 2006;28(9):713–717
  15. Lin CY, Ding HJ, Liu CS, Chen YK, Lin CC, Kao CH. Correlation between the intensity of breast FDG uptake and menstrual cycle. Acad Radiol. 2007;14(8):940–944
  16. Meier JM, Alavi A, Iruvuri S, Alzeair S, Parker R, Houseni M, et al. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med. 2007;37(3):154–172
  17. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, et al Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest. 1992;89(6):1958–1963
  18. Enomoto K, Fukunaga T, Okazumi S, Asano T, Kikuchi T, Yamamoto H, et al Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma. Kaku Igaku. 1991;28(11):1353–1356
  19. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–S168
  20. Lu JN, Chen CJ. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res. 1991;11(1):229–233
  21. Craxì A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med. 2008;29(1-2):85–95
  22. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999;59(3):290–296
  23. Sahdev P, Garramone RR, Schwartz RJ, Steelman SR, Jacobs LM. Evaluation of liver function tests in screening for intra-abdominal injuries. Ann Emerg Med. 1991;20(8):838–841
  24. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med. 2003;163(2):218–224
  25. Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, et al. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol. 2002;97(11):2855–2860

PII: S0899-7071(09)00115-6

doi: 10.1016/j.clinimag.2009.05.007

Clinical Imaging
Volume 34, Issue 2 , Pages 109-112 , March 2010

Article Tools

* Image Usage & Resolution